Literature DB >> 8419641

Sequence variation of human endogenous retrovirus ERV9-related elements in an env region corresponding to an immunosuppressive peptide: transcription in normal and neoplastic cells.

M Lindeskog1, P Medstrand, J Blomberg.   

Abstract

Evolutionarily conserved sequences corresponding to an immunosuppressive region in retroviral transmembrane proteins were amplified by the polymerase chain reaction from human genomic DNA and reverse-transcribed RNA from one glioma, three pieces of macroscopically normal brain tissue, kidney, lymphocytes, cultured embryonic lung cells, and a rhabdomyosarcoma cell line. Amplification products (125 bp) from DNA and RNA from the glioma and RNA from one normal piece of brain tissue were cloned and sequenced (45 clones). A variety of sequences similar to ERV9 (75 to 93%) were identified. Amplification products were immobilized on nylon filters and hybridized to four different synthetic oligonucleotides derived from the sequenced clones. Sequences without the stop codon seen in ERV9 in this region, possibly encoding functional immunosuppressive proteins, were present in RNA amplificates from all samples. The various cell types showed different hybridization patterns with the four probes. The open reading frame sequences were identified in genomic Southern blots, one probe detecting about 10 copies and another detecting a single copy. Northern (RNA) blots of mRNA from various normal human tissues revealed 2.5-kb (e.g., lung) and 10-kb (e.g., placenta) transcripts hybridizing to one of the probes.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8419641      PMCID: PMC237471     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  29 in total

1.  Inhibition of protein kinase C by a peptide conjugate homologous to a domain of the retroviral protein p15E.

Authors:  R A Gottlieb; E S Kleinerman; C A O'Brian; S Tsujimoto; G J Cianciolo; W J Lennarz
Journal:  J Immunol       Date:  1990-10-15       Impact factor: 5.422

2.  Inhibition of human lymphocyte mitogen and antigen response by a 15,000-dalton protein from feline leukemia virus.

Authors:  L C Hebebrand; R G Olsen; L E Mathes; W S Nichols
Journal:  Cancer Res       Date:  1979-02       Impact factor: 12.701

3.  Macrophage accumulation in mice is inhibited by low molecular weight products from murine leukemia viruses.

Authors:  G J Cianciolo; T J Matthews; D P Bolognesi; R Snyderman
Journal:  J Immunol       Date:  1980-06       Impact factor: 5.422

4.  Nucleotide sequence of Moloney murine leukaemia virus.

Authors:  T M Shinnick; R A Lerner; J G Sutcliffe
Journal:  Nature       Date:  1981 Oct 15-21       Impact factor: 49.962

5.  Characterization of a large genomic size Moloney murine sarcoma virus produced by a transformed rat cell line.

Authors:  J Devaux; M A Buendia; R Hamelin; C Bernard; A Tavitian
Journal:  J Gen Virol       Date:  1982-11       Impact factor: 3.891

6.  Isolation of a type D retrovirus from B-cell lymphomas of a patient with AIDS.

Authors:  R C Bohannon; L A Donehower; R J Ford
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

7.  Effects of CKS-17, a synthetic retroviral envelope peptide, on cell-mediated immunity in vivo: immunosuppression, immunogenicity, and relation to immunosuppressive tumor products.

Authors:  M Nelson; D S Nelson; G J Cianciolo; R Snyderman
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

8.  Inhibitors of monocyte responses to chemotaxins are present in human cancerous effusions and react with monoclonal antibodies to the P15(E) structural protein of retroviruses.

Authors:  G Cianciolo; J Hunter; J Silva; J S Haskill; R Snyderman
Journal:  J Clin Invest       Date:  1981-10       Impact factor: 14.808

9.  Human adult T-cell leukemia virus: complete nucleotide sequence of the provirus genome integrated in leukemia cell DNA.

Authors:  M Seiki; S Hattori; Y Hirayama; M Yoshida
Journal:  Proc Natl Acad Sci U S A       Date:  1983-06       Impact factor: 11.205

10.  Study of the expression of a glycoprotein of retroviral origin in the plasma of patients with hematologic disorders and in the plasma of normal individuals.

Authors:  P C Jacquemin; P Strijckmans; L Thiry
Journal:  Blood       Date:  1984-10       Impact factor: 22.113

View more
  6 in total

1.  ERV3 and related sequences in humans: structure and RNA expression.

Authors:  Ann-Catrin Andersson; Zhihong Yun; Göran O Sperber; Erik Larsson; Jonas Blomberg
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

2.  Endogenous retroviruses in the human genome--a point of view.

Authors:  Y Becker
Journal:  Virus Genes       Date:  1995-02       Impact factor: 2.332

3.  Characterization of novel reverse transcriptase encoding human endogenous retroviral sequences similar to type A and type B retroviruses: differential transcription in normal human tissues.

Authors:  P Medstrand; J Blomberg
Journal:  J Virol       Date:  1993-11       Impact factor: 5.103

4.  Molecular characterization and placental expression of HERV-W, a new human endogenous retrovirus family.

Authors:  J L Blond; F Besème; L Duret; O Bouton; F Bedin; H Perron; B Mandrand; F Mallet
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

Review 5.  Demystified. Human endogenous retroviruses.

Authors:  P N Nelson; P R Carnegie; J Martin; H Davari Ejtehadi; P Hooley; D Roden; S Rowland-Jones; P Warren; J Astley; P G Murray
Journal:  Mol Pathol       Date:  2003-02

6.  Expression of ecotropic murine leukemia virus in the brains of C58/M, DBA2/J, and in utero-infected CE/J mice.

Authors:  G W Anderson; P G Plagemann
Journal:  J Virol       Date:  1995-12       Impact factor: 5.103

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.